Key facts
- This page summarizes Richard Chen's Form 4 filing for Personalis, Inc. (PSNL).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 31 Jan 2024, 16:30.
Richard Chen - 29 Jan 2024 Form 4 Insider Report for Personalis, Inc. (PSNL)
- Reporting relationship
- CHIEF MEDICAL OFFICER AND EVP
- Issuer ticker
- PSNL
- Reported as of
- 29 Jan 2024
- Net transaction value
- -$721
- SEC form
- 4
- Accepted by SEC
- 31 Jan 2024, 16:30:33 UTC
- Prior SEC filing
- 19 Dec 2023
- Next SEC filing
- 19 Mar 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Aaron Tachibana, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Richard Chen filed Form 4 for Personalis, Inc. (PSNL) on 31 Jan 2024.
Change
- Previous filing in this sequence was filed on 19 Dec 2023.
- Current net transaction value: -$721.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PSNL
transaction
Common Stock
Sale
- Transaction value
- $721
- Shares
- -526
- Change %
- -0.41%
- Price
- $1.37
- Shares after
- 128,870
- Date
- 29 Jan 2024
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units.